Jean-Frédéric Blanc Selected Research

Jean-Frédéric Blanc Research Topics

Disease

41	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 06/2002
33	Neoplasms (Cancer) 02/2024 - 06/2002
13	Adenocarcinoma 10/2023 - 05/2003
10	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021 - 10/2014
7	Fibrosis (Cirrhosis) 02/2021 - 08/2015
6	Liver Neoplasms (Liver Cancer) 02/2023 - 12/2012
5	Neoplasm Metastasis (Metastasis) 03/2024 - 06/2002
5	Hemorrhage 02/2024 - 08/2009
4	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2024 - 07/2014
4	Liver Cell Adenoma (Hepatocellular Adenoma) 02/2024 - 09/2007
3	Disease Progression 05/2024 - 07/2014
2	Portal Hypertension 10/2023 - 08/2015
2	Focal Nodular Hyperplasia 01/2022 - 12/2017
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2019
2	Diarrhea 01/2020 - 07/2008
2	Neutropenia 01/2019 - 07/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 07/2014
2	Hypertension (High Blood Pressure) 01/2018 - 10/2013
2	Body Weight (Weight, Body) 01/2014 - 01/2007
1	Cholangiocarcinoma 03/2024
1	Inflammation (Inflammations) 02/2024
1	Margins of Excision 11/2023
1	Hepatitis B 10/2023
1	Acute Intermittent Porphyria (Porphyria, Acute) 10/2022
1	Tics (Tic) 01/2022
1	Infections 01/2019
1	Hand-Foot Syndrome 01/2019
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019

Drug/Important Bio-Agent (IBA)

13	Sorafenib (BAY 43-9006)FDA Link 11/2022 - 07/2008
10	Gemcitabine FDA Link 05/2024 - 07/2014
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 11/2016
7	Leucovorin (Folinic Acid)FDA Link 01/2021 - 05/2017
7	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 05/2017
6	CateninsIBA 02/2024 - 12/2013
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2005
5	Matrix Metalloproteinases (MMPs)IBA 01/2007 - 06/2002
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2023 - 05/2017
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2013
4	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2022 - 10/2015
4	beta CateninIBA 01/2020 - 09/2007
4	BilirubinIBA 01/2019 - 08/2015
3	Bevacizumab (Avastin)FDA Link 10/2023 - 11/2022
3	atezolizumabIBA 10/2023 - 11/2022
3	CyclinsIBA 01/2022 - 10/2015
3	folfirinoxIBA 01/2019 - 12/2015
3	Peptide Hydrolases (Proteases)FDA Link 10/2006 - 06/2002
2	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2021
2	durvalumabIBA 05/2024 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 07/2014
2	tepotinibIBA 08/2021 - 01/2021
2	Pravastatin (Pravachol)FDA LinkGeneric 02/2021 - 01/2007
2	PlatinumIBA 01/2021 - 07/2014
2	Messenger RNA (mRNA)IBA 01/2020 - 10/2007
2	ApolipoproteinsIBA 01/2020 - 09/2005
2	cabozantinibIBA 01/2020 - 01/2020
2	AlbuminsIBA 01/2020 - 12/2016
2	Antiviral Agents (Antivirals)IBA 01/2019 - 11/2018
2	Transaminases (Aminotransferases)IBA 01/2019 - 07/2014
2	Cyclin A2IBA 12/2018 - 10/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2016 - 07/2014
2	Adenosine Triphosphatases (ATPase)IBA 12/2012 - 10/2007
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 05/2003 - 06/2002
1	spleen fibrinolytic proteinase (human) (SFP)IBA 03/2024
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 02/2024
1	Glutamine (L-Glutamine)FDA Link 02/2024
1	abemaciclibIBA 10/2023
1	LY3023414IBA 10/2023
1	LY-2157299IBA 10/2023
1	tislelizumabIBA 02/2023
1	Programmed Cell Death 1 ReceptorIBA 02/2023
1	IpilimumabIBA 01/2023
1	PorphyrinsIBA 10/2022
1	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 10/2022
1	EnzymesIBA 10/2022
1	PorphobilinogenIBA 10/2022
1	A-Form DNA (A-DNA)IBA 10/2022
1	Heme (Haem)IBA 10/2022
1	Contrast MediaIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 12/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Taxoids (Taxanes)IBA 01/2021
1	tremelimumabIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	VaccinesIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	regorafenibIBA 01/2020

Therapy/Procedure

14	Therapeutics 02/2023 - 07/2008
11	Drug Therapy (Chemotherapy) 10/2023 - 05/2012
6	Radiofrequency Ablation 03/2024 - 11/2006
4	Immunotherapy 02/2024 - 01/2021
3	Radiotherapy 12/2023 - 10/2014
3	Neoadjuvant Therapy 09/2021 - 10/2014
1	Adjuvant Chemotherapy 03/2024
1	Critical Care (Surgical Intensive Care) 11/2021
1	Drug Tapering 01/2021
1	Chemoradiotherapy 01/2019